_________________
May 9, 2023 | An elite biotechnology company selected ValGenesis VLMS for digitizing multiple validation processes across the organization. The company selected ValGenesis VLMS after a rigorous audit of solutions.
ValGenesis News
An elite biotechnology company selected ValGenesis VLMS for digitizing multiple validation processes across the organization. The company selected ValGenesis VLMS after a rigorous audit of solutions.
ValGenesis, Inc., the market leader in enterprise Validation Lifecycle Management Systems (VLMS), and MEPHARMA, a strategic regulatory consulting services company, have partnered to provide a range of regulatory intelligence, compliance, and validation and automation solutions for companies in the United Arab Emirates (UAE) and the Middle East and North Africa (MENA).
ValGenesis Process Manager is designed to eliminate these commonly cited observations by digitizing, automating, and controlling the end-to-end cleaning validation lifecycle, all aligned to the FDA's lifecycle approach for cleaning validation.
ValGenesis, Inc., the market leader in enterprise Validation Lifecycle Management Systems (VLMS), and VTI Life Sciences (VTI), a leader in the field of commissioning, qualification, and validation (CQV) as well as automation services, have partnered to provide pharmaceutical, biotechnology and medical device manufacturers a full range of validation, automation, and quality systems services for their cGMP/GLP facilities.
ValGenesis and ProQuality Network are helping companies evaluate digital transformation solutions in line with Pharma 4.0 requirements with special focus on quality and compliance.
ValGenesis Design Manager, a new module within VLMS 4.2 that is ready for computer software assurance (CSA) out of the box. As a new module within VLMS 4.2, Design Manager enables any company to develop risk-based requirements and apply critical thinking to validation processes.
ValGenesis, Inc., the market leader in enterprise validation lifecycle management solutions, announced that Continuus Pharmaceuticals, an end-to-end integrated continuous manufacturing (ICM) company, successfully went live with the ValGenesis Validation Lifecycle Management System (VLMS) to efficiently manage validation processes across the company as 100% digital.
The strategic alliance will offer global pharmaceutical companies a streamlined, software-based solution to enhance quality assurance across their global supply chains.
ValGenesis, Inc., the market leader in enterprise Validation Lifecycle Management Systems (VLMS), and Enterey, a specialist life sciences consulting company, have partnered to deliver Pharma 4.0-focused digital transformation services and solutions for life sciences companies across the U.S.
ValGenesis and Scignyte provide an integrated governance approach with streamlined collaboration and data integrity, further strengthening risk and compliance across R&D processes.